Advanced search
Publication Cover
International Journal of Cardiovascular Interventions Volume 4, 2001 - Issue 4
Journal homepage
7
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Percutaneous intervention of old degenerated saphenous vein grafts

Jose A Silva Department of Cardiology Ochsner Heart and Vascular Institute, New Orleans, Louisiana, USA.
&
Christopher J White Department of Cardiology Ochsner Heart and Vascular Institute, New Orleans, Louisiana, USA.
Pages 187-194 | Published online: 10 Jul 2009

  • Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth cell proliferation. J Am Coll Cardiol 1990; 15: 1667-1687.
  • Ratliff NB, Myles JL. Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible immunemediated disease. Arch Pathol Lab Med 1989; 113: 772-776.
  • Walts AE, Fishbein MC, Matloff JM. Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years' experience. Am Heart J 1987; 114: 718-723.
  • Smith SH, Geer JC. Morphology of saphenous vein-coronary artery bypass grafts: seven to 116 months after surgery. Arch Pathol Lab Med 1983; 107: 13-18.
  • Suva JA, White CJ, Collins TJ, Ramee SR. Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein grafts with intracoronary angioscopy in patients with unstable angina. Am Heart J 1998; 136: 156-163.
  • FitzGibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographie follow-up of 5065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996; 28: 616-626.
  • Loop FD, Lytle BW, Cosgrove DM et al. Reoperation for coronary atherosclerosis. Changing practice in 2509 consecutive patients. Ann Surg 1990; 212: 378-386.
  • Cameron A, Kemp HG, Green GE. Reoperation for coronary artery disease. 10 years of clinical follow-up. Circulation 1988; 78(Suppl 1) 1: 158-162.
  • De Feyter PJ, Van Suylen RJ, de Jaegere PP , Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein grafts. J Am Coll Cardiol 1993; 21: 1539-1549.
  • Lefkovits J, Holmes DR, Califf RM et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial: Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation 1995; 92: 734-740.
  • Ellis SG, Brener SJ, DeLuca S et al. Late myocardial ischemic events after saphenous vein graft intervention -- importance of initially 'nonsignificant' vein graft lesions. Am J Cardiol 1997; 79: 1460-1464.
  • Hong MK, Mehran R, Dangas G et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999; 100: 2400-2405.
  • Holmes DR Jr, Topol EJ, Califf RM et al, the CAVEAT-II Investigators. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation 1995; 91: 1966-1974.
  • Safian RD, Grines CL, May MA et al. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994; 89: 302-312.
  • Savage MP, Douglas JS Jr, Fischman DL et al, for the Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997; 337: 740-747.
  • Choussat R, Black AJ, Bossi I, Joseph T, Fajadet J, Marco J. Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents. J Am Coll Cardiol 2000; 36: 387-394
  • Briguori C, Sheiban I, De Gregorio J et al. Direct coronary stenting without predilation. J Am Coll Cardiol 1999; 34: 1910-1915.
  • Hamon M, Richardeau Y, Lecluse E et al. Direct coronary stenting without balloon predilatation in acute coronary syndromes. Am Heart J 1999; 138: 55-59.
  • Dooris M, Hoffmann M, Glazier S et al. Comparative results of transluminal extraction coronary atherectomy in saphenous vein grafts lesions with and without thrombus. J Am Coll Cardiol 1995; 25: 1700-1705.
  • Ramee SR, Kuntz RE, Schatz RA et al. Preliminary experience with the POSSlS coronary AngioJet Rheolytic thrombectomy catheter in the VeGAS 1 pilot study (abstract). J Am Coll Cardiol 1996; 27(Suppl A): 69A.
  • Ramee SR, Baim DS, Popma JJ et al. A randomized prospective multicenter study comparing intracoronary urokinase to rheolytic thrombectomy with the Possis Angiojet catheter for intracoronary thrombus: final result of the VeGAS 2 Trial (abstract). Circulation 1998; 98(Suppl I): 1-86.
  • Miller DL, Thomas RM, Williams AR. Mechanisms for hemolysis by ultrasonic cavitation in the rotating exposure system. Ultrasound Med Biol 1991; 17: 171-178.
  • Miller DL, Williams AR. Bubble cycling as the explanation of the promotion of ultrasonic cavitation in a rotating tube exposure system. Ultrasound Med Biol 1989; 15: 641-648.
  • Rosenschein U, Gaul G, Erbel R et al. Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation 1999; 99: 26-29.
  • Schieman G, Cohen BM, Kozina J et al. lntracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes. Circulation 1990; 82: 2052-2060.
  • Vaitkus PT, Laskey WK. Efficacy of adjunctive thrombolytic therapy in percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994; 24: 1415-1423.
  • Denardo SJ, Morris NB, Rocha-Singh KJ, Curtis GP, Rubenson DS, Teirstein PS. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts. Am J Cardiol 1995; 76: 776-780.
  • Neumann FJ, Blasini R, Schmitt C et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary artery stents in acute myocardial infarction. Circulation 1998; 98: 2695-2701.
  • Mak KH, Challapalli R, Eisenberg MJ, Anderson KM, Califf RM, Topol LJ, for the EPIC Investigators. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol 1997; 80: 985-988.
  • Ellis SG, Lincoff AM, Miller D et al. Reduction of complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998; 32: 1619-1623.
  • Piana RN, Paik GY, Moscucci M et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994; 89: 2514-2518.
  • Kaplan BM, Benzuly KH, Kinn JW et al. Treatment of noreflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn 1996; 39: 113-118.
  • Abbo KM, Dooris M, Glazier S et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995; 75: 778-782.
  • Kloner RA, Canote CL, Jennings RB. The 'no-reflow' phenomenon following temporary coronary occlusion in the dog. J Clin Invest 1974; 54: 1496-1508.
  • Wilson RL, Laxson DD, Lesser JR, White CW. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989; 1(8642): 807-811.
  • Lischell TA, Carter AJ, Loster MT et al. Reversal of 'no-reflow' during vein graft stenting using high velocity boluses of intracoronary adenosine. Cathet Cardiovasc Diag 1998; 45: 360-365.
  • Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001; 37: 1335-1343.
  • Rawitscher D, Levin TN, Cohen I, Feldman T. Rapid reversal of no-reflow using abciximab after coronary device intervention. Cathet Cardiovasc Diag 1997; 42: 187-190.
  • Gurbel PA, Criado FJ, Curnutte EA, Patten P, Secada-Lovio J. Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent. Cathet Cardiovasc Diagn 1997; 40: 75-78.
  • Stefanadis C, Toutouzas K, Tsiamis E et al. Total reconstruction of a diseased saphenous vein graft by means of conventional and autologous tissue-coated stents. Cathet Cardiovasc Diagn 1998; 43: 318-321.
  • Stefanadis C, Tsiamis E, Vlachopoulos C et al. Autologous vein graft-coated stents for the treatment of thrombus-containing coronary artery lesions. Cathet Cardiovasc Diagn 1997; 40: 217-222.
  • Malik N, Gunn J, Newman C, Crossman DC, Cumberland DC. Phosporylcholine coated stents: Angiographie and morphometric assessment in porcine coronary arteries (abstract). J Am CoIl Cardiol 1998; 31(Suppl A): 414A.
  • Stefanadis C, Toutouzas K, Tsiamis E et al. Clinical and angiographie follow-up after autologous vein graft-coated stent implantation (abstract). J Am Coll Cardiol 1998; 31 (Suppl A): 351A.
  • Toutouzas K, Stefanadis C, Tsiamis E et al. Stents coated by an autologous arterial graft: The first application in human coronary arteries (abstract). J Am Coll Cardiol 1998; 31 (SupplA): 351A.
  • Stefanadis C, Tsiamis E, Toutouzas K et al. Autologous vein graft-coated stent for the treatment of coronary artery disease: Immediate results after percutaneous implantation in humans (abstract). J Am Coll Cardiol 1996; 27(Suppl A): 179.
  • Muramatsu T, Tukahara R, Hou M, lto S, Inoue T. Immediate results and dilatation effect of the vein-covered Palmaz-Schatz stent assessed by intravascular ultrasound. Cathet Cardiovasc Diagn 1998; 44: 276-282.
  • Carlino M, De Gregorio J, Di Mario C et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system. Circulation 1999; 99: 3221-3223.
  • Baim DS, Dennis W, George B et al. On behalf of the Saphenous Vein Graft Angioplasty Free of Emboli Randomized (SAFER) trial investigators. Circulation 2001; 105: 1285-1290.
  • Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101: 570-580.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.